- Release Date: 12/07/13 18:24
- Summary: RELINT: FPH: Disclosure of Directors and Officers Relevant Interests
- Price Sensitive: No
- Download Document 9.25KB
FPH 12/07/2013 16:24 RELINT REL: 1624 HRS Fisher & Paykel Healthcare Corporation Limited RELINT: FPH: Disclosure of Directors and Officers Relevant Interests A Details of director or officer Name of director or officer of public issuer: Antony John CARTER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Director B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: "(i) 91 Ordinary Shares (ii) 1,197 Ordinary Shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities "(i) Antony Carter Family Trust No 2 (ii) Loughborough Investments Limited" D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 5 July 2013 Consideration paid for acquisition: "(i) NZ$299.18 (ii) NZ$3,964.48" If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration received for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: "(i) Purchase of 91 Ordinary Shares under the Dividend Reinvestment Plan; (ii) Purchase of 1,197 Ordinary Shares under the Dividend Reinvestment Plan." E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 21 December 2012 Name of director or officer of public issuer: Arthur James MORRIS Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Director B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 167 Ordinary Shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Niloc Trust D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 5 July 2013 Consideration paid for acquisition: NZ$553.30 If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration received for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: Purchase of 167 Ordinary Shares under the Dividend Reinvestment Plan. E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 7 December 2012 Name of director or officer of public issuer: Donal Paul O'DWYER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Director B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1,085 Ordinary Shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Dundrum Super Fund D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 5 July 2013 Consideration paid for acquisition: AUD$3,007.07 If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration received for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: Purchase of 1,085 Ordinary Shares under the Dividend Reinvestment Plan E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 15 January 2013 Name of director or officer of public issuer: Michael Grenfell DANIELL Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Managing Director/Chief Executive Officer B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 14,421 Ordinary Shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Daniell Family Trust D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition 5 July 2013 Consideration paid for acquisition NZ$47,779.66 If the relevant interest was disposed of-- Date of disposal Not applicable Consideration received for disposal Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place Purchase of 14,421 ordinary shares under the Dividend Reinvestment Plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 18 December 2012 Name of director or officer of public issuer: Nigel Thomas EVANS Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Director B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 417 Ordinary Shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Nigel Thomas EVANS and Janette Elizabeth EVANS D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 5 July 2013 Consideration paid for acquisition: NZ$1,381.60 If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration received for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: Purchase of 417 Ordinary Shares under the Dividend Reinvestment Plan E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 21 December 2012 Name of director or officer of public issuer: Antony George BARCLAY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Chief Financial Officer & Company Secretary B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: 746 Ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Antony George BARCLAY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 5 July 2013 Consideration paid for acquisition: NZ$2,471.65 If the relevant interest was disposed of-- Date of disposal: Not applicable Consideration received for disposal: Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: Purchase of 746 Ordinary shares under the Dividend Reinvestment Plan E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 21 December 2012 Name of director or officer of public issuer: Winston FONG Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President ICT B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities 60 Ordinary Shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Winston FONG D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition 5 July 2013 Consideration paid from acquisition NZ$198.79 If the relevant interest was disposed of-- Date of disposal Not Applicable Consideration received for disposal Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place Purchase of 60 Ordinary Shares under the Dividend Reinvestment Plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 18 December 2012 End CA:00238560 For:FPH Type:RELINT Time:2013-07-12 16:24:41
Ann: RELINT: FPH: Disclosure of Directors and Off
Add to My Watchlist
What is My Watchlist?
